乳がんの休眠状態の適応生存メカニズムを解読する

Francis M Barnieh¹, Jamie Morton², Olaitan Olanrewaju²

¹Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK. f.mprahbarnieh1@bradford.ac.uk.

Oncogene

|August 27, 2025

まとめ

乳がんの再発は休眠中の腫瘍細胞によって引き起こされますこれらの細胞がどうやって生き延びるかを知ることは癌の再発を防ぐ新しい治療法の開発に鍵となるものです

科学分野:

腫瘍学
癌生物学

背景:

乳がん (BC) の再発は重要な臨床問題であり,しばしば不活性な腫瘍細胞によって引き起こされます.
BCの休眠状態を調節するメカニズムは十分に理解されていないため,効果的な治療法の開発を妨げています.

研究の目的:

乳がんの休眠状態を誘発する要因を検討する
休眠状態のBC細胞の生存メカニズムを調べる
BCの再発を防ぐための治療戦略を特定する.

主な方法:

乳がんの休眠期に関する臨床前および臨床研究の文献レビュー.
腫瘍低酸素,細胞外マトリックス (ECM) 再構成,治療によるストレスなどの要因の分析.
休眠状態のBC細胞における細胞代謝,遺伝子発現,免疫相互作用の評価

主要な成果:

腫瘍の低酸素,ECMの改造,治療によるストレスがBCの休眠状態の主要な要因です.
休眠状態のBC細胞は細胞代謝の変化,遺伝子発現,免疫逃避によって生き残る.
現行の臨床前モデルでは,臨床応用への結果の翻訳に制限があります.

結論:

BCの休眠メカニズムのより深い理解は,ターゲットを絞った治療法の開発に不可欠です.
休眠状態のBC細胞を根絶する戦略は,再発を防ぐために必要である.
臨床前モデルの欠陥を補うことで,臨床的転用が容易になり,患者の治療結果が改善されます.

さらに関連する動画

09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.0K

07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

4.7K

関連する概念動画

02:40

Cancer Stem Cells and Tumor Maintenance

5.0K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

5.0K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

01:21

Cancer Survival Analysis

448

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

448

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

02:23

Abnormal Proliferation

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

4.6K

02:07

Tumor Progression

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...